Nov. 12 at 7:31 PM
$PPCB
Hi mortimerT, thanks for sharing your thoughts.
Propanc Biopharma remains fully focused on advancing its oncology research and developing next-generation cancer therapies. The company’s recent financing agreement is designed to strengthen its financial flexibility and support long-term R&D goals. For full details, please refer to our latest press release.
Disclaimer: This account is managed by Propanc Biopharma’s Investor Relations team to share accurate, publicly available information. No investment advice is provided.